Durcan FJ, Corbett JJ, Wall M: The incidence of pseudotumor cerebri. Population studies in Iowa and Louisiana. Arch Neurol 1988, 45:875–877.
Garrett J, Corbett JJ, Braswell RA, Santiago M: The increasing incidence of IIH. The effect of obesity on frequency of occurrence in Mississippi. Ann Neurol 2004, 56(Suppl 8):S69.
Daniels AB, Liu GT, Volpe NJ, et al.: Profiles of obesity, weight gain, and quality of life in idiopathic intracranial hypertension (pseudotumor cerebri). Am J Ophthalmol 2007, 143:635–641.
Balcer LJ, Liu GT, Forman S, et al.: Idiopathic intracranial hypertension: relation of age and obesity in children. Neurology 1999, 52:870–872.
Digre KB, Corbett JJ: Pseudotumor cerebri in men. Arch Neurol 1988, 45:866–872.
Ireland B, Corbett JJ, Wallace RB: The search for causes of idiopathic intracranial hypertension. A preliminary casecontrol study. Arch Neurol 1990, 47:315–320.
Giuseffi V, Wall M, Siegel PZ, Rojas PB: Symptoms and disease associations in idiopathic intracranial hypertension (pseudotumor cerebri): a case-control study. Neurology 1991, 41:239–244.
Boulton M, Armstrong D, Flessner M, et al.: Raised intracranial pressure increases CSF drainage through arachnoid villi and extracranial lymphatics. Am J Physiol 1998, 275(3 Pt 2):889–896.
Koh L, Nagra G, Johnston M: Properties of the lymphatic cerebrospinal fluid transport system in the rat: impact of elevated intracranial pressure. J Vasc Res 2007, 44:423–432.
Sahs AL, Joynt RJ: Brain swelling of unknown cause. Neurology 1956, 6:791–803.
Wall M, Dollar JD, Sadun AA, Kardon R: Idiopathic intracranial hypertension: lack of histologic evidence for cerebral edema. Arch Neurol 1995, 52:141–145.
Wall M: The headache profile of idiopathic intracranial hypertension. Cephalalgia 1990, 10:331–335.
Friedman DI, Rausch EA: Headache diagnoses in patients with treated idiopathic intracranial hypertension. Neurology 2002, 58:1551–1553.
Meador KJ, Swift TR: Tinnitus from intracranial hypertension. Neurology 1984, 34:1258–1261.
Farb RI, Vanek I, Scott JN, et al.: Idiopathic intracranial hypertension: the prevalence and morphology of sinovenous stenosis. Neurology 2003, 60:1418–1424.
Wall M, White WN: Asymmetric papilledema in idiopathic intracranial hypertension: prospective interocular comparison of sensory visual function. Invest Ophthalmol Vis Sci 1998, 39:134–142.
Wall M, George D: Idiopathic intracranial hypertension. A prospective study of 50 patients. Brain 1991, 114:155–180.
Smith JL: Whence pseudotumor cerebri?
J Clin Neuroophthalmol 1985, 5:55–56.
Neville L, Egan RA: Frequency and amplitude of elevation of cerebrospinal fluid resting pressure by the Valsalva maneuver. Can J Ophthalmol 2005, 40:775–777.
Whiteley W, Al Shahi R, Warlow CP, et al.: CSF opening pressure: reference interval and the effect of body mass index. Neurology 2006, 67:1690–1691.
Bono F, Quattrone A: CSF opening pressure: reference interval and the effect of body mass index. Neurology 2007, 68:1439–1440.
Corbett JJ, Mehta MP: Cerebrospinal fluid pressure in normal obese subjects and patients with pseudotumor cerebri. Neurology 1983, 33:1386–1388.
Bono F, Lupo MR, Serra P, et al.: Obesity does not induce abnormal CSF pressure in subjects with normal cerebral MR venography. Neurology 2002, 59:1641–1643.
Yeh YC, Tang HF, Fang IM: Pseudotumor cerebri caused by all-trans-retinoic acid treatment for acute promyelocytic leukemia. Jpn J Ophthalmol 2006, 50:295–296.
Winn BJ, Liao YJ, Horton JC: Intracranial pressure returns to normal about a month after stopping tetracycline antibiotics. Arch Ophthalmol 2007, 125:1137–1138.
Ang ER, Zimmerman JC, Malkin E: Pseudotumor cerebri secondary to minocycline intake. J Am Board Fam Pract 2002, 15:229–233.
Wall M: Papilledema and idiopathic intracranial hypertension (pseudotumor cerebri). In Neurological Therapeutics Principles and Practice. Edited by Noseworthy JH. Abingdon, UK: Informa Healthcare; 2006:1955–1968.
Newborg B: Pseudotumor cerebri treated by rice reduction diet. Arch Intern Med 1974, 133:802–807.
Johnson LN, Krohel GB, Madsen RW, March GA Jr: The role of weight loss and acetazolamide in the treatment of idiopathic intracranial hypertension (pseudotumor cerebri). Ophthalmology 1998, 105:2313–2317.
Kupersmith MJ, Gamell L, Turbin R, et al.: Effects of weight loss on the course of idiopathic intracranial hypertension in women. Neurology 1998, 50:1094–1098.
Wong R, Madill SA, Pandey P, Riordan-Eva P: Idiopathic intracranial hypertension: the association between weight loss and the requirement for systemic treatment. BMC Ophthalmol 2007, 7:15.
Sugerman HJ, Felton WL III, Sismanis A, et al.: Gastric surgery for pseudotumor cerebri associated with severe obesity. Ann Surg 1999, 229:634–640.
Johnston I, Paterson A: Benign intracranial hypertension. II. CSF pressure and circulation. Brain 1974, 97:301–312.
Scoffings DJ, Pickard JD, Higgins JN: Resolution of transverse sinus stenoses immediately after CSF withdrawal in idiopathic intracranial hypertension. J Neurol Neurosurg Psychiatry 2007, 78:911–912.
McCarthy KD, Reed DJ: The effect of acetazolamide and furosemide on CSF production and choroid plexus carbonic anhydrase activity. J Pharmacol Exp Ther 1974, 189:194–201.
Gucer G, Vierenstein L: Long-term intracranial pressure recording in management of pseudotumor cerebri. J Neurosurg 1978, 49:256–263.
Tomsak RL, Niffenegger AS, Remler BF: Treatment of pseudotumor cerebri with Diamox (acetazolamide). J Clin Neuro-ophthalmol 1988, 8:93–98.
Celebisoy N, Gokcay F, Sirin H, Akyurekli O: Treatment of idiopathic intracranial hypertension: topiramate vs acetazolamide, an open-label study. Acta Neurol Scand 2007, 116:322–327.
Zimran A, Beutler E: Can the risk of acetazolamide-induced aplastic anemia be decreased by periodic monitoring of blood cell counts?
Am J Ophthalmol 1987, 104:654–658.
Shah VA, Fung S, Shahbaz R, et al.: Idiopathic intracranial hypertension. Ophthalmology 2007, 114:617.
Corbett JJ: The 1982 Silversides lecture. Problems in the diagnosis and treatment of pseudotumor cerebri. Can J Neurol Sci 1983, 10:221–229.
Pollay M, Fullenwider C, Roberts PA, Stevens FA: Effect of mannitol and furosemide on blood-brain osmotic gradient and intracranial pressure. J Neurosurg 1983, 59:945–950.
Kessler LA, Novelli PM, Reigel DH: Surgical treatment of benign intracranial hypertension-subtemporal decompression revisited. Surg Neurol 1998, 50:73–76.
Goh KY, Schatz NJ, Glaser JS: Optic nerve sheath fenestration for pseudotumor cerebri. J Neuroophthalmol 1997, 17:86–91.
Acheson JF, Green WT, Sanders MD: Optic nerve sheath decompression for the treatment of visual failure in chronic raised intracranial pressure. J Neurol Neurosurg Psychiatr 1994, 57:1426–1429.
Sergott RC, Savino PJ, Bosley TM: Modified optic nerve sheath decompression provides long-term visual improvement for pseudotumor cerebri. Arch Ophthalmol 1988, 106:1391–1397.
Corbett JJ, Nerad JA, Tse D, Anderson RL: Optic nerve sheath fenestration for pseudotumor cerebri: the lateral orbitotomy approach. Arch Ophthalmol 1988, 106:1391–1397.
Plotnik JL, Kosmorsky GS: Operative complications of optic nerve sheath decompression. Ophthalmology 1993, 100:683–690.
Brourman ND, Spoor TC, Ramocki JM: Optic nerve sheath decompression for pseudotumor cerebri. Arch Ophthalmol 1988, 106:1378–1383.
Chandrasekaran S, McCluskey P, Minassian D, Assaad N: Visual outcomes for optic nerve sheath fenestration in pseudotumour cerebri and related conditions. Clin Exp Ophthalmol 2006, 34:661–665.
Curry WT Jr, Butler WE, Barker FG: Rapidly rising incidence of cerebrospinal fluid shunting procedures for idiopathic intracranial hypertension in the United States, 1988-2002. Neurosurgery 2005, 57:97–108.
Eggenberger ER, Miller NR, Vitale S: Lumboperitoneal shunt for the treatment of pseudotumor cerebri. Neurology 1996, 46:1524–1530.
Rosenberg M, Smith C, Beck R: The efficacy of shunting procedures in pseudotumor cerebri. Neurology 1989, 39:209.
Burgett RA, Purvin VA, Kawasaki A: Lumboperitoneal shunting for pseudotumor cerebri. Neurology 1997, 49:734–739.
Johnston I, Besser M, Morgan MK: Cerebrospinal fluid diversion in the treatment of benign intracranial hypertension. J Neurosurg 1988, 69:195–202.
McGirt MJ, Woodworth G, Thomas G, et al.: Cerebrospinal fluid shunt placement for pseudotumor cerebri-associated intractable headache: predictors of treatment response and an analysis of long-term outcomes. J Neurosurg 2004, 101:627–632.
King JO, Mitchell PJ, Thomson KR, Tress BM: Manometry combined with cervical puncture in idiopathic intracranial hypertension. Neurology 2002, 58:26–30.
Friedman DI: Cerebral venous pressure, intra-abdominal pressure, and dural venous sinus stenting in idiopathic intracranial hypertension. J Neuroophthalmol 2006, 26:61–64.